ASPEGIC for children 250 mg, powder for oral solution in a single-dose sachet 20 sachets
Active ingredients: Aspirin, Aspirin DL-lysine
Commercialized according to BDPM
Powder for oral solution20 sachetsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ASPEGIC ENFANTS 250 mg, poudre pour solution buvable en sachet-dose
- Pharmaceutical form
- poudre pour solution buvable
- Route of administration
- orale
- Presentation description
- 20 sachet(s)-dose(s) aluminium polyéthylène basse densité (PEBD) de 511,5 mg
- Marketing authorisation holder
- SUBSTIPHARM
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Nov 1984
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66311831CIP73270361CIP133400932703616Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ACIDE ACÉTYLSALICYLIQUEpoudre | 250 mg · un sachet de 511,5 mg | FT |
| DL-LYSINE (ACÉTYLSALICYLATE DE)poudre | 450 mg · un sachet de 511,5 mg | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.